Together we can create a future where everyone affected by tuberous sclerosis complex can live their fullest lives.
To improve quality of life for everyone affected by tuberous sclerosis complex by catalyzing new treatments, driving research toward a cure and expanding access to lifelong support.
TSC Alliance and Apertura Gene Therapy Complete Preclinical Pilot Study Evaluating AAV Gene Therapy Approach Designed for TSC1
Learn more
For two and one-half decades, Kari has dedicated her life’s work to building a future where everyone affected by tuberous sclerosis complex (TSC) has what they need to live their fullest lives. She joined the organization in 2001 and has…...
May 5, 2026 – Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering…...
Registration for the 2026 Step Forward to Cure TSC® Walk Season is open! Whether…...
Currently, a lot of outcomes are being measured that are not always relevant or impactful…...
Join the TSC Alliance for five webinars that will help you build a strong foundation of knowledge…...
Last year, when funding for the TSCRP and other Congressionally Directed Medical Research Programs was…...
Register today for the 2026 TSC World Conference from July 30 to August 1, 2026,…...
The TSC Alliance has launched a Reproductive and Perinatal Health Initiative committed to improving care…...
